This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oral Controlled Release Drug Delivery Technology Market

Oral Controlled Release Drug Delivery Technology: An Ideal Alternative to Combat the Problem Associated with Conventional Drug Delivery!

Oral Controlled Release Drug Delivery Technology Market by Drug Release System, Dosage Form & Region - Forecast 2022 – 2032

Oral Controlled Release Drug Delivery Technology Market Outlook (2022-2032)

[222 Pages Report] The global oral controlled release drug delivery technology market is poised to grow from US$ 34.1 Bn in 2022 to US$ 68.4 Bn by 2032, with overall demand expected to surge at 7.2% CAGR throughout the forecast period (2022–2032). Rising incidence of chronic diseases coupled with growing preference for oral drug delivery due to its various benefits is the key factor driving demand for oral controlled release drug delivery technology.

Based on form, the solid dosage forms segment is expected to lead the global oral controlled release drug delivery technology market throughout the forecast period with an estimated share of nearly 87%.

Attribute

Key Statistics

Oral Controlled Release Drug Delivery Technology Market Base Value (2021)

US$ 31.8 Bn

Estimated Market Value (2022)

US$ 34.1 Bn

Projected Market Value (2032)

US$ 68.4 Bn

Value-based CAGR (2022-2032)

7.2%

Market share of Top 5 countries

62.1%

The oral controlled release drug delivery system is designed to deliver a drug in controlled and predictable manner over a period of time or at a predetermined position in the gastrointestinal tract. Oral dosage forms are preferred for their convenience and cost-effectiveness.

Oral controlled release drug delivery technologies like, Geolock, Geomatrix, OROS (osmotic-controlled release drug delivery system), SODAS (Spheroidal oral drug absorption system), and many more are exclusively used for most of pharmaceutical drug candidates and are most common form to deliver a medication to patients.

Oral solid dosage forms coupled with new drug release mechanisms such as dissolution and diffusion controlled drug release delivery systems are expected to remain mainstay in the global pharmaceuticals market as these type of new and enhanced drug delivery systems with the use of advanced polymers tend to be important part of drug development technology and approvals of new chemical entities.

The overall oral controlled release drug delivery technology market formed nearly 14% of the global pharmaceutical drug delivery market which was valued at around US$ 230 Bn in 2021

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analyses of Oral Controlled Release Drug Delivery Technology Market 2012-2021 Vs Market outlook for 2022-2032.

Sales in oral controlled release drug delivery technology market are projected to rise at 7.2% CAGR during the forecast period between 2022 to 2032, in comparison to 6.5% CAGR registered from 2012 to 2021.

Growing demand for specialized oral dosage forms such as pediatric or geriatric tablets with controlled release drug delivery systems, adoption rate of new developed and innovative technologies such as nanotechnology, osmotically controlled release, hydrophilic ion exchange etc. are the prime factors expected to drive the growth of oral controlled release drug delivery technology market over the forecast period.

Oral drug delivery has become the most preferred and convenient option as the oral route provides maximum active surface area among all drug delivery systems for administration of various drugs.

Increasing generic penetration is another important factor pushing the growth of global market. Oral solid dosage forms such as tablets and capsules, represent the largest growth opportunity for generic players.

Some other factors influencing growth of global oral controlled release drug delivery technology market include cost-effective generic dosage forms, R&D scientists and healthcare professionals’ preference to sustained release controlled delivery coupled with new biopolymers embedded with advanced coating technology in solid dosage forms, liquids and semisolids.

Furthermore, the combination of various technologies to overcome the limitations of poorly soluble substance/drugs/chemicals and higher adoption rate of these combined products/technologies at convenient pricing is expected to boost the oral controlled release drug delivery technology market.

In addition to this, increasing approval of modified and extended release oral dosage forms by various health ministries across the world is likely to drive the market.

Oral Controlled Release Drug Delivery Technology Market Download Report Brochure

What are the Key Trends Driving the Global Oral Controlled Release Drug Delivery Technology Market?

“Rise in Chronic Diseases and Advancement in Drug Delivery Techniques to Boost Market Growth”

As per FMI, the global oral controlled release drug delivery technology market is projected to expand at a robust pace during the forecast period, owing to the rising prevalence of chronic and infectious diseases like cancer, T.B. heart disease, diabetes, etc. and increasing spending on oral medications.

Similarly, continuous efforts of manufacturers to develop and produce novel complex drug products with customized release trends will propel the expansion of oral controlled release drug delivery technology market globally during the forecast years.

Use of combination techniques such as modified controlled release mechanisms and other platforms which uses ion exchange release (hydrophilic & hydrophobic), osmotically controlled release, diffusion & dissolution (combined) controlled release in new drug formulation procedures is on the rise across healthcare industry and the trend is likely to continue during the forecast period.

Also, introduction of super generics, continuous new technology launches, and growing number of contract manufacturing facilities for oral solid dosage forms & liquid dosage forms and enhanced patient compliance are expected to create lucrative market growth opportunities during the forecast period.

According to a research published in the Journal of Controlled Release, it has been found that ‘casein’ based formulations are probable contenders for controlled release drug delivery system, because of their properties like, high tensile strength and presence of naturally occurring genipin, tissue enzyme & transglutaminase. Casein can also be used as cross-linkers to prepare novel casein-based hydrogels for the controlled release of bioactive.

Similarly, growing usage of 3D printing technology for designing and manufacturing oral formulations is expected to create lucrative opportunities for oral controlled release drug delivery system manufacturers.

3D printing technique can be used to produce multiple doses of drugs at small scale and to improve drug formulations. 3D printing technology can be a great prospect for manufacturers to impose in their innovative, research and development department for drug formulations.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are Factors Restraining the Growth in Oral Controlled Release Drug Delivery Technology Market?

Formulation challenges are mainly drug related – active pharmaceutical ingredients with short half-life and the necessity for higher-dose delivery and formulation related, which regularly require dissolvable handling capacities in light of the fact that most polymers should be solubilized in natural solvents before covering the controlled-release formulations (i.e., tablets, granules and capsules)

Growing research towards biologic molecules and their dominance in treating oncology conditions are expected to hamper the growth of the oral controlled release drug delivery technology market over the forecast period.

According to an article published in Contract pharma, approximately 50% of the pipeline molecules are biologics and the rest in the form of other dosage forms.

However, low pipeline productivity of oral solids is the major factor hindering the growth of oral controlled release drug delivery technology market.

Other factors include complex supply chain and stringent regulatory requirements, decreasing productivity coupled with low R&D expenditure, product related issues such as dose dumping and product recalls.

Country Wise Insights

Why is the the U.S. Leading Oral Controlled Release Drug Delivery Technology Market?

“Rising Spending on Medicines Fuelling Market Growth in the U.S.”

The U.S. oral controlled release drug delivery technology market reached a valuation of over US$ 11.0 Bn in 2021 and is expected to grow over a CAGR of 7.0% during the forecast period (2022-2032).

Rising prevalence of chronic diseases such as cancer and diabetes, supporting initiatives & campaigns from the government, and investments in research & development are driving b growth in the U.S. market and the trend is likely to continue during the forecast period.

Similarly, strong presence of major key players in the country and their promotional strategies for adoption of controlled release drug delivery systems are expected to expand the oral controlled release drug delivery technology market in the future.

In addition to this, increasing spending on medicines across the country will create opportunities for oral controlled release drug delivery technology manufacturers in future. In fact, the U.S. is the highest spending country worldwide when it comes to health care.

According to the U.S. Department of Health and Human Services, U.S. prescription drug expenditures totalled an enormous valuation of US$370 billion in 2019 and this number is likely to further surge during the assessment period.

What is the Demand Outlook in Germany Oral Controlled Release Drug Delivery Technology Market?

Rising Prevalence of Heart Diseases Driving Demand Across Germany”

As of 2021, Germany held a revenue share of 21.5% of total European oral controlled release drug delivery technology market and it is estimated to grow at a healthy pace during the forecast period.

The German oral controlled release drug delivery technology market will likely be driven by improved patient compliance, rising geriatric and paediatric populations, and increased demand for controlled release drug delivery systems due to the prevalence of chronic diseases.

Over the years, there has been a sharp rise in cases of heart disease across Germany leading to a high death rate. Oral solid dosages are utilised very commonly for the treatment of the same. As per the World Health Organization (WHO) insights in 2019, nearly 37% of deaths in Germany were due to circulatory diseases.

Thus, growing demand for oral solid dosage together with rising prevalence for circulatory disease is expected to boost Germany’s oral controlled release drug delivery technology market during the next ten years.

Why is Japan Emerging as the Fastest Growing Oral Controlled Release Drug Delivery Technology Market?

“Growing Preference for Oral Medication Fostering Market Growth in Japan”

The overall oral controlled release drug delivery technology market in Japan reached US$ 2.6 Bn in 2021 and it is expected to expand at a CAGR of around 6.7% during the forecast period. This can be attributed to the rising popularity of oral medication among the country’s rapidly growing population, advancements in pharmaceutical sector, and increasing investments in R&D activities by biopharma companies.

Similarly, increasing healthcare spending and high levels of health awareness among the general public are expected to bolster the growth of oral controlled release drug delivery technology market in Japan during the forthcoming years.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category Wise Insights

Which is the Most Popular Drug Release System in Oral Controlled Release Drug Delivery Technology Market?

“Demand Remains High for Dissolution Controlled Release System”

The dissolution controlled release system segment dominated the global oral controlled release drug delivery technology market with a revenue share of nearly 45% in 2021 and the trend is projected to continue throughout the forecast period.

Properties such as maximum efficacy with minimal side effects and reduced drug accumulation with drug level fluctuation are the major reasons for adoption of this technique.

The dissolution controlled release system provides sustained release profiles i.e., In dissolution controlled release system, the active drugs are released continuously at a slow rate to provide a long-term therapeutic effect. Thus, they provide a sustained release profile, which is encouraging their adoption across the world.

Which Dosage Form Remains Highly Preferred Among End Users?

“End Users Prefer Solid Dosage Forms”

As per FMI, the solid dosage forms segment generated revenue of around US$ 27 Bn in the global oral controlled release drug delivery technology market in 2021 and it is poised to grow at a higher CAGR over the next ten years. This can be attributed to the rising end user preference for solid dosage forms.

Owing to the better physical and chemical stability, lower manufacturing costs, and easy to consume & carry features of solid dosage forms, it remains highly popular among end users. People are increasingly opting for solid dosage forms like tablets, capsules and powders to treat various diseases.

Competitive Landscape

Some of the key players identified in global oral controlled release drug delivery technology market are AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., and Johnson & Johnson.

These players are trying to combine new molecular entities with existing ones to explore clinical indications for controlled release mechanisms, which in turn is propelling the discovery of new matrix systems in oral controlled release drug delivery technology market. Furthermore, they are partnering and collaborating with other companies to increase their revenue share. For instance,

  • In January 2020, Adare Pharmaceuticals Inc. collaborated with NLS pharmaceuticals and developed a product ‘Mazindol (MZD)’- Controlled release product, for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD).
  • In 2020, Bristol Myers Squibb announced the commercial launch and availability of ZEPOSIA®(ozanimod) 0.92 mg, a new once-daily oral medication for adults for the treatment of relapsing forms of multiple sclerosis (RMS).
  • In 2022, Sandoz, a Novartis division, acquired Coalesce Product Development Limited, the UK-based medical and drug delivery device development company.

Report Scope as per Oral Controlled Release Drug Delivery Technology Industry Analysis

Attribute

Details

Estimated Market Size (2022)

US$ 34.1 Bn

Projected Market Size (2032)

US$ 68.4 Bn

Anticipated Growth Rate (2022-2032)

7.2%

Forecast Period

2022-2032

Historical Data Available for

2012-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa (MEA).

Key Countries Covered

USA, Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA.

Key Market Segments Covered

Drug Release System, Dosage Form, Region

Key Companies Profiled

AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., Johnson & Johnson, GlaxoSmithKline Plc., Sun Pharmaceuticals, Sanofi S.A., Boehringer Ingelheim, AbbVie, Takeda, Eli Lilly, Bayer, Gilead Sciences, Amgen, BioNTech, Viatris, Moderna.

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Market Segments Covered in the Oral Controlled Release Drug Delivery Technology Market Research

Drug Release System:

  • Dissolution Controlled Release System
  • Diffusion Controlled Release System
  • Osmotically Controlled Release System
  • Dissolution and Diffusion Controlled Release System
  • Ion Exchange Resins Controlled Release System
  • Hydro-dynamically Balanced Drug Delivery System
  • Others

Dosage Form:

  • Solid Dosage Forms
  • Semisolid/Liquid/Suspensions

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global oral controlled release drug delivery technology market is estimated to be valued at US$ 34.1 Bn in 2022.

The global oral controlled release drug delivery technology market is anticipated to reach a valuation of about US$ 68.4 Bn by the end of 2032.

As per FMI, the global oral controlled release drug delivery technology market is expected to grow at around 7.2% CAGR during the forecast period.

North America will continue to dominate the global oral controlled release drug delivery technology, exhibiting a growth rate of 6.9% CAGR throughout the forecast period.

With a valuation of nearly US$ 27 Bn in 2021, the solid dosage forms segment will continue to lead the global oral controlled release drug delivery technology market.

AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., Johnson & Johnson, GlaxoSmithKline Plc., and Sun Pharmaceuticals are the major players operating in the global market.

Increasing adoption rates of the newer technologies, growing incidence of chronic diseases, increasing geriatric & paediatric population, and investments in research & development activities are some of the major factors driving the global oral controlled release drug delivery technology market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology, by Region

    4.2. Key promotional strategies by manufacturers

    4.3. Regulatory Landscape

    4.4. Value chain analysis

    4.5. Drug Release System adoption analysis

    4.6. PESTEL Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Increasing Complexity of Healthcare Operations

        5.2.3. Drug Release System Pricing

        5.2.4. Strategic Collaborations amongst Players

        5.2.5. Rising Prevalence of Infections and Surgical Procedures

        5.2.6. Adoption Rate

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID 002D19 and Impact Analysis

        6.1.1. By Drug Release System

        6.1.2. By Dosage Form

        6.1.3. By Country

    6.2. 2021 Market Scenario

7. Global Oral Controlled Release Drug Delivery Technology Market Demand (in Value) Analysis 2012–2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2012–2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032, By Drug Release System

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis, By Drug Release System, 2012–2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Drug Release System, 2022–2032

        8.3.1. Dissolution Controlled Release System

        8.3.2. Diffusion Controlled Release System

        8.3.3. Osmotically Controlled Release System

        8.3.4. Dissolution & Diffusion Controlled Release System

        8.3.5. Ion Exchange Resins Controlled Release

        8.3.6. Hydrodynamically Balanced Drug Delivery System

        8.3.7. Others

    8.4. Market Attractiveness Analysis, by Drug Release System

9. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032, By Dosage Form

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis, By Dosage Form, 2012–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Dosage Form, 2022–2032

        9.3.1. Solid Dosage Form

        9.3.2. Semisolid/Liquid/Suspensions

    9.4. Market Attractiveness Analysis, by Dosage Form

10. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032, By Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis, by Region, 2012–2021

    10.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis, by Region

11. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012–2021

    11.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Drug Release System

        11.3.3. By Dosage Form

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Drug Release System

        11.4.3. By Dosage Form

    11.5. Market Trends

    11.6. Drivers and Restraints - Impact Analysis

    11.7. Country Level Analysis & Forecast

        11.7.1. U.S. Oral Controlled Release Drug Delivery Technology Market Analysis

            11.7.1.1. Introduction

            11.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                11.7.1.2.1. By Drug Release System

                11.7.1.2.2. By Dosage Form

        11.7.2. Canada Oral Controlled Release Drug Delivery Technology Market Analysis

            11.7.2.1. Introduction

            11.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                11.7.2.2.1. By Drug Release System

                11.7.2.2.2. By Dosage Form

12. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2012–2021

    12.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        12.3.1. By Country

            12.3.1.1. Mexico

            12.3.1.2. Brazil

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Drug Release System

        12.3.3. By Dosage Form

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug Release System

        12.4.3. By Dosage Form

    12.5. Market Trends

    12.6. Drivers and Restraints - Impact Analysis

    12.7. Country Level Analysis & Forecast

        12.7.1. Mexico Oral Controlled Release Drug Delivery Technology Market Analysis

            12.7.1.1. Introduction

            12.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                12.7.1.2.1. By Drug Release System

                12.7.1.2.2. By Dosage Form

        12.7.2. Brazil Oral Controlled Release Drug Delivery Technology Market Analysis

            12.7.2.1. Introduction

            12.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                12.7.2.2.1. By Drug Release System

                12.7.2.2.2. By Dosage Form

        12.7.3. Argentina Oral Controlled Release Drug Delivery Technology Market Analysis

            12.7.3.1. Introduction

            12.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                12.7.3.2.1. By Drug Release System

                12.7.3.2.2. By Dosage Form

13. Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2012–2021

    13.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Drug Release System

        13.3.3. By Dosage Form

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug Release System

        13.4.3. By Dosage Form

    13.5. Market Trends

    13.6. Drivers and Restraints - Impact Analysis

    13.7. Country Level Analysis & Forecast

        13.7.1. Germany Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.1.1. Introduction

            13.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.1.2.1. By Drug Release System

                13.7.1.2.2. By Dosage Form

        13.7.2. Italy Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.2.1. Introduction

            13.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.2.2.1. By Drug Release System

                13.7.2.2.2. By Dosage Form

        13.7.3. France Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.3.1. Introduction

            13.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.3.2.1. By Drug Release System

                13.7.3.2.2. By Dosage Form

        13.7.4. U.K. Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.4.1. Introduction

            13.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.4.2.1. By Drug Release System

                13.7.4.2.2. By Dosage Form

        13.7.5. Spain Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.5.1. Introduction

            13.7.5.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.5.2.1. By Drug Release System

                13.7.5.2.2. By Dosage Form

        13.7.6. BENELUX Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.6.1. Introduction

            13.7.6.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.6.2.1. By Drug Release System

                13.7.6.2.2. By Dosage Form

        13.7.7. Russia Oral Controlled Release Drug Delivery Technology Market Analysis

            13.7.7.1. Introduction

            13.7.7.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.7.2.1. By Drug Release System

                13.7.7.2.2. By Dosage Form

14. East Asia Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Distribution Channel (US$ Mn) Trend Analysis, by Market Taxonomy, 2012–2021

    14.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Drug Release System

        14.3.3. By Dosage Form

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Drug Release System

        14.4.3. By Dosage Form

    14.5. Market Trends

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. China Oral Controlled Release Drug Delivery Technology Market Analysis

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.1.2.1. By Drug Release System

                14.7.1.2.2. By Dosage Form

        14.7.2. Japan Oral Controlled Release Drug Delivery Technology Market Analysis

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.2.2.1. By Drug Release System

                14.7.2.2.2. By Dosage Form

        14.7.3. South Korea Oral Controlled Release Drug Delivery Technology Market Analysis

            14.7.3.1. Introduction

            14.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.3.2.1. By Drug Release System

                14.7.3.2.2. By Dosage Form

15. South Asia Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2012–2021

    15.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Indonesia

            15.3.1.3. Malaysia

            15.3.1.4. Thailand

            15.3.1.5. Rest of South Asia

        15.3.2. By Drug Release System

        15.3.3. By Dosage Form

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug Release System

        15.4.3. By Dosage Form

    15.5. Market Trends

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. India Oral Controlled Release Drug Delivery Technology Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.1.2.1. By Drug Release System

                15.7.1.2.2. By Dosage Form

        15.7.2. Indonesia Oral Controlled Release Drug Delivery Technology Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.2.2.1. By Drug Release System

                15.7.2.2.2. By Dosage Form

        15.7.3. Malaysia Oral Controlled Release Drug Delivery Technology Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.3.2.1. By Drug Release System

                15.7.3.2.2. By Dosage Form

        15.7.4. Thailand Oral Controlled Release Drug Delivery Technology Market Analysis

            15.7.4.1. Introduction

            15.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.4.2.1. By Drug Release System

                15.7.4.2.2. By Dosage Form

16. Oceania Oral Controlled Release Drug Delivery Technology Market 2012-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2012–2021

    16.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Drug Release System

        16.3.3. By Dosage Form

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug Release System

        16.4.3. By Dosage Form

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. Australia Oral Controlled Release Drug Delivery Technology Market Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.1.2.1. By Drug Release System

                16.7.1.2.2. By Dosage Form

        16.7.2. New Zealand Oral Controlled Release Drug Delivery Technology Market Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.2.2.1. By Drug Release System

                16.7.2.2.2. By Dosage Form

17. Middle East and Africa (MEA) Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2012–2021

    17.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Turkey

            17.3.1.3. South Africa

            17.3.1.4. Israel

            17.3.1.5. North Africa

            17.3.1.6. Rest of Middle East and Africa

        17.3.2. By Drug Release System

        17.3.3. By Dosage Form

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Drug Release System

        17.4.3. By Dosage Form

    17.5. Market Trends

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. GCC Countries Oral Controlled Release Drug Delivery Technology Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.1.2.1. By Drug Release System

                17.7.1.2.2. By Dosage Form

        17.7.2. Turkey Oral Controlled Release Drug Delivery Technology Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.2.2.1. By Drug Release System

                17.7.2.2.2. By Dosage Form

        17.7.3. South Africa Oral Controlled Release Drug Delivery Technology Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.3.2.1. By Drug Release System

                17.7.3.2.2. By Dosage Form

        17.7.4. Israel Oral Controlled Release Drug Delivery Technology Market Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.4.2.1. By Drug Release System

                17.7.4.2.2. By Dosage Form

        17.7.5. North Africa Oral Controlled Release Drug Delivery Technology Market

            17.7.5.1. Introduction

            17.7.5.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.5.2.1. By Drug Release System

                17.7.5.2.2. By Dosage Form

18. Market Structure Analysis

    18.1. Market Analysis, by Tier of Companies

    18.2. Market Share Analysis of Top Players

    18.3. Market Presence Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. AstraZeneca Plc.

            19.3.1.1. Overview

            19.3.1.2. Drug Release System Portfolio

            19.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.1.4. Sales Footprint

            19.3.1.5. Key Financials

            19.3.1.6. SWOT Analysis

            19.3.1.7. Strategy Overview

        19.3.2. Bristol-Myers Squibb Company

            19.3.2.1. Overview

            19.3.2.2. Drug Release System Portfolio

            19.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.2.4. Sales Footprint

            19.3.2.5. Key Financials

            19.3.2.6. SWOT Analysis

            19.3.2.7. Strategy Overview

        19.3.3. Merck & Co. Inc.

            19.3.3.1. Overview

            19.3.3.2. Drug Release System Portfolio

            19.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.3.4. Sales Footprint

            19.3.3.5. Key Financials

            19.3.3.6. SWOT Analysis

            19.3.3.7. Strategy Overview

        19.3.4. Novartis AG

            19.3.4.1. Overview

            19.3.4.2. Drug Release System Portfolio

            19.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.4.4. Sales Footprint

            19.3.4.5. Key Financials

            19.3.4.6. SWOT Analysis

            19.3.4.7. Strategy Overview

        19.3.5. Pfizer Inc.

            19.3.5.1. Overview

            19.3.5.2. Drug Release System Portfolio

            19.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.5.4. Sales Footprint

            19.3.5.5. Key Financials

            19.3.5.6. SWOT Analysis

            19.3.5.7. Strategy Overview

        19.3.6. F. Hoffman-La-Roche Ltd.

            19.3.6.1. Overview

            19.3.6.2. Drug Release System Portfolio

            19.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.6.4. Sales Footprint

            19.3.6.5. Key Financials

            19.3.6.6. SWOT Analysis

            19.3.6.7. Strategy Overview

        19.3.7. Johnson & Johnson

            19.3.7.1. Overview

            19.3.7.2. Drug Release System Portfolio

            19.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.7.4. Sales Footprint

            19.3.7.5. Key Financials

            19.3.7.6. SWOT Analysis

            19.3.7.7. Strategy Overview

        19.3.8. GlaxoSmithKline Plc.

            19.3.8.1. Overview

            19.3.8.2. Drug Release System Portfolio

            19.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.8.4. Sales Footprint

            19.3.8.5. Key Financials

            19.3.8.6. SWOT Analysis

            19.3.8.7. Strategy Overview

        19.3.9. Sun Pharmaceuticals

            19.3.9.1. Overview

            19.3.9.2. Drug Release System Portfolio

            19.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.9.4. Sales Footprint

            19.3.9.5. Key Financials

            19.3.9.6. SWOT Analysis

            19.3.9.7. Strategy Overview

        19.3.10. Sanofi S.A.

            19.3.10.1. Overview

            19.3.10.2. Drug Release System Portfolio

            19.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.10.4. Sales Footprint

            19.3.10.5. Key Financials

            19.3.10.6. SWOT Analysis

            19.3.10.7. Strategy Overview

        19.3.11. Boehringer Ingelheim

            19.3.11.1. Overview

            19.3.11.2. Drug Release System Portfolio

            19.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.11.4. Sales Footprint

            19.3.11.5. Key Financials

            19.3.11.6. SWOT Analysis

            19.3.11.7. Strategy Overview

        19.3.12. AbbVie

            19.3.12.1. Overview

            19.3.12.2. Drug Release System Portfolio

            19.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.12.4. Sales Footprint

            19.3.12.5. Key Financials

            19.3.12.6. SWOT Analysis

            19.3.12.7. Strategy Overview

        19.3.13. Takeda

            19.3.13.1. Overview

            19.3.13.2. Drug Release System Portfolio

            19.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.13.4. Sales Footprint

            19.3.13.5. Key Financials

            19.3.13.6. SWOT Analysis

            19.3.13.7. Strategy Overview

        19.3.14. Eli Lilly

            19.3.14.1. Overview

            19.3.14.2. Drug Release System Portfolio

            19.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.14.4. Sales Footprint

            19.3.14.5. Key Financials

            19.3.14.6. SWOT Analysis

            19.3.14.7. Strategy Overview

        19.3.15. Bayer

            19.3.15.1. Overview

            19.3.15.2. Drug Release System Portfolio

            19.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.15.4. Sales Footprint

            19.3.15.5. Key Financials

            19.3.15.6. SWOT Analysis

            19.3.15.7. Strategy Overview

        19.3.16. Gilead Sciences

            19.3.16.1. Overview

            19.3.16.2. Drug Release System Portfolio

            19.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.16.4. Sales Footprint

            19.3.16.5. Key Financials

            19.3.16.6. SWOT Analysis

            19.3.16.7. Strategy Overview

        19.3.17. Amgen

            19.3.17.1. Overview

            19.3.17.2. Drug Release System Portfolio

            19.3.17.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.17.4. Sales Footprint

            19.3.17.5. Key Financials

            19.3.17.6. SWOT Analysis

            19.3.17.7. Strategy Overview

        19.3.18. BioNTech

            19.3.18.1. Overview

            19.3.18.2. Drug Release System Portfolio

            19.3.18.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.18.4. Sales Footprint

            19.3.18.5. Key Financials

            19.3.18.6. SWOT Analysis

            19.3.18.7. Strategy Overview

        19.3.19. Viatris

            19.3.19.1. Overview

            19.3.19.2. Drug Release System Portfolio

            19.3.19.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.19.4. Sales Footprint

            19.3.19.5. Key Financials

            19.3.19.6. SWOT Analysis

            19.3.19.7. Strategy Overview

        19.3.20. Moderna

            19.3.20.1. Overview

            19.3.20.2. Drug Release System Portfolio

            19.3.20.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.20.4. Sales Footprint

            19.3.20.5. Key Financials

            19.3.20.6. SWOT Analysis

            19.3.20.7. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 02: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032By Dosage Form

Table 03: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032 by Region

Table 04: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 05: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 06: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Dosage Form

Table 07: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 08: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 09: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Dosage Form

Table 10: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 11: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 12: Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032 By Dosage Form

Table 13: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 14: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 15: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Dosage Form

Table 16: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 17: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 18: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Dosage Form

Table 19: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 20: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 21: Oceania Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032By Dosage Form

Table 22: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 by Country

Table 23: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032 By Drug Release System

Table 24: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2021 and Forecast 2022–2032 By Dosage Form

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 02: Global Oral Controlled Release Drug Delivery Technology Market Forecast & Y-o-Y Growth 2022–2032

Figure 03: Global Oral Controlled Release Drug Delivery Technology Market Absolute $ Opportunity (US$ Mn) Analysis 2021–2032

Figure 04: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 By Drug Release System

Figure 05: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022-2032 By Drug Release System

Figure 06: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022–2032 By Drug Release System

Figure 07: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 By Dosage Form

Figure 08: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022-2032 By Dosage Form

Figure 09: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022–2032 By Dosage Form

Figure 10: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 by Region

Figure 11: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022-2032 by Region

Figure 12: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022–2032 by Region

Figure 13: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 14: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 15: North America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 16: North America Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 17: North America Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 18: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 19: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 20: U.S. Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 21: Global Vs. U.S. Growth Comparison 2022 - 2032

Figure 22: U.S. Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 23: U.S. Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 24: Canada Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 25: Global Vs. Canada. Growth Comparison 2022 - 2032

Figure 26: Canada Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 27: Canada Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 28: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 29: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 30: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 31: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 32: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 33: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 34: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022–2032

Figure 35: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 36: Mexico Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 37: Global Vs Mexico Growth Comparison 2022 - 2032

Figure 38: Mexico Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 39: Mexico Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 40: Brazil Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 41: Global Vs. Brazil. Growth Comparison 2022 - 2032

Figure 42: Brazil Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 43: Brazil Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 44: Argentina Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 45: Global Vs Argentina Growth Comparison 2022 - 2032

Figure 46: Argentina Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 47: Argentina Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 48: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 49: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 50: Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 51: Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 52: Europe Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 53: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 54: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022–2032

Figure 55: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 56: UK Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 57: Global Vs. UK Growth Comparison 2022 - 2032

Figure 58: UK Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 59: UK Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 60: Germany Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 61: Global Vs. Germany Growth Comparison 2022 - 2032

Figure 62: Germany Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 63: Germany Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 64: Italy Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 65: Global Vs. Italy Growth Comparison 2022 - 2032

Figure 66: Italy Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 67: Italy Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 68: France Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 69: Global Vs France Growth Comparison 2022 - 2032

Figure 70: France Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 71: France Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 72: Spain Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 73: Global Vs Spain Growth Comparison 2022 - 2032

Figure 74: Spain Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 75: Spain Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 76: Russia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 77: Global Vs Russia Growth Comparison 2022 - 2032

Figure 78: Russia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 79: Russia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 80: BENELUX Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 81: Global Vs BENELUX Growth Comparison 2022 - 2032

Figure 82: BENELUX Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 83: BENELUX Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 84: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 85: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 86: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 87: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 88: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 89: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 90: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022–2032

Figure 91: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 92: China Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 93: Global Vs. China Growth Comparison 2022 - 2032

Figure 94: China Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 95: China Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 96: Japan Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 97: Global Vs. Japan Growth Comparison 2022 - 2032

Figure 98: Japan Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 99: Japan Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 100: South Korea Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 101: Global Vs South Korea Growth Comparison 2022 - 2032

Figure 102: South Korea Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 103: South Korea Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 104: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 105: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 106: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 107: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 108: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 109: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 110: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022–2032

Figure 111: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 112: India Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 113: Global Vs. India Growth Comparison 2022 - 2032

Figure 114: India Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 115: India Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 116: Indonesia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 117: Global Vs. Indonesia Growth Comparison 2022 - 2032

Figure 118: Indonesia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 119: Indonesia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 120: Malaysia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 121: Global Vs. Malaysia Growth Comparison 2022 - 2032

Figure 122: Malaysia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 123: Malaysia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 124: Thailand Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 125: Global Vs. Thailand Growth Comparison 2022 - 2032

Figure 126: Thailand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 127: Thailand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 128: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 129: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 130: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 131: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 132: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 133: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 134: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022–2032

Figure 135: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 136: Australia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 137: Global Vs. Australia Growth Comparison 2022 - 2032

Figure 138: Australia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 139: Australia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 140: New Zealand Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 141: Global Vs New Zealand Growth Comparison 2022 - 2032

Figure 142: New Zealand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 143: New Zealand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 144: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis 2012–2021

Figure 145: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Forecast 2022-2032

Figure 146: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)

Figure 147: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)

Figure 148: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)

Figure 149: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022–2032

Figure 150: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022–2032

Figure 151: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022–2032

Figure 152: GCC Countries Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 153: Global Vs GCC Countries Growth Comparison 2022 - 2032

Figure 154: GCC Countries Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 155: GCC Countries Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 156: Turkey Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 157: Global Vs. Turkey Growth Comparison 2022 - 2032

Figure 158: Turkey Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 159: Turkey Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 160: South Africa Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 161: Global Vs. South Africa Growth Comparison 2022 - 2032

Figure 162: South Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 163: South Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Figure 164: North Africa Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021

Figure 165: Global Vs North Africa Growth Comparison 2022 - 2032

Figure 166: North Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 & 2032

Figure 167: North Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pharmaceutical Drug Delivery Market

Published : February 2022

Packaging

Drug Delivery Solutions Market

Published : January 2022

Healthcare

Oral Solid Dosage Pharmaceutical Formulation Market

Published : July 2017

Healthcare

Drug Delivery Technology Market

Published : January 2016

Google translate

Oral Controlled Release Drug Delivery Technology Market